Business
Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC
Cell MedX Corp. to Attend the 29th Annual Wellness Show 2022 Held in Vancouver, BC.
About this update from Stimcell Energetics Inc.
[{"type":"text","content":"Carson City, Nevada--(Newsfile Corp. - March 24, 2022) - Cell MedX Corp. (OTCQB: CMXC) (\"Cell MedX\" or the \"Company\"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it will be participating as an exhibitor at the 29th Annual Wellness Show held at Vancouver Convention Centre, East Building, on March 26th - 27th. The Wellness Show is a host of Western Canada's biggest and most established health and lifestyles showcase. It brings new approaches to nutrition, fitness, physical and emotional well-being to help Vancouverites achieve their most holistic, healthiest selves. In addition to the annual showcase, The Wellness Show helps to connect like-minded businesses and thought-leaders in wellness, educate the public on health options as a year-round online resource at https://www.thewellnessshow.com/Brad Hargreaves, the Company's VP Technology and Operations, stated, \"We look forward to exhibiting at The Wellness Show and demonstrating our eBalance® Home/Pro Systems. Please come by Booth 520 as our team I will be there to answer your questions.\"About Cell MedX Corp. (OTCQB: CMXC) Cell MedX Corp. is a biotech company focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness and alleviate complications associated with medical conditions including, but not limited to: diabetes, Parkinson's disease, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance® Technology and its eBalance® Home and eBalance® Pro Systems, which have received Health Canada Approval as Class II Medical Device Systems in the summer of 2020. For more information about the Company and its technology please visit www.cellmedx.com/investors/overview/. For the Company's newsletter please visit: www.cellmedx.com/media/newsletters/On behalf of the Board of Directors of Cell MedX Corp. Frank McEnultyCEOForward-Looking StatementsThe information included in this press release has not been reviewed by the FDA or Health Canada, nor has it been peer reviewed. This press release contains forward-looking statements. Forward-looking statements are subject to risks, unce...